These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26637499)

  • 1. In vitro and in vivo characterization of CYP inhibition by 1-aminobenzotriazole in rats.
    Parrish KE; Mao J; Chen J; Jaochico A; Ly J; Ho Q; Mukadam S; Wright M
    Biopharm Drug Dispos; 2016 May; 37(4):200-11. PubMed ID: 26637499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo use of the CYP inhibitor 1-aminobenzotriazole to increase long-term exposure in mice.
    Watanabe A; Mayumi K; Nishimura K; Osaki H
    Biopharm Drug Dispos; 2016 Sep; 37(6):373-8. PubMed ID: 27379984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atipamezole is a promising non-discriminative inhibitor against pan-CYP450 including diclofenac 4'-hydroxylation: A comparison with ABT for drug ADME optimization and mechanism study.
    Li Z; Zhang Y; Gao Y; Xiang Y; Zhang W; Lu C; Zhuang X
    Eur J Pharm Sci; 2019 Mar; 130():156-165. PubMed ID: 30690186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations in human liver microsomes: a comparison with SKF-525A.
    Emoto C; Murase S; Sawada Y; Iwasaki K
    Drug Metab Pharmacokinet; 2005 Oct; 20(5):351-7. PubMed ID: 16272753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 1-Aminobenzotriazole and Ketoconazole as Novel Inhibitors of Monoamine Oxidase (MAO): An In Vitro Investigation.
    Shaik AN; LeDuc BW; Khan AA
    Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):827-834. PubMed ID: 28185143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearance.
    Strelevitz TJ; Foti RS; Fisher MB
    J Pharm Sci; 2006 Jun; 95(6):1334-41. PubMed ID: 16625658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Aminobenzotriazole, a known cytochrome P450 inhibitor, is a substrate and inhibitor of N-acetyltransferase.
    Sun Q; Harper TW; Dierks EA; Zhang L; Chang S; Rodrigues AD; Marathe P
    Drug Metab Dispos; 2011 Sep; 39(9):1674-9. PubMed ID: 21677062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro and In Vivo Correlation of Hepatic Fraction of Metabolism by P450 in Dogs.
    Zhou X; Hui YH; Hudson L; Katyayan KK; Mohutsky MA; Hao J; Schober DA; Hembre EJ
    J Pharm Sci; 2019 Feb; 108(2):1017-1026. PubMed ID: 30244007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in the systemic exposure of primary metabolites of Midazolam in rat arising from CYP inhibition or hepatic dysfunction.
    Hasegawa T; Nakanishi S; Minami K; Higashino H; Kataoka M; Shitara Y; Yamashita S
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):69-76. PubMed ID: 28109684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of pharmacokinetic profiles of verapamil and drug-drug interactions induced by a CYP inhibitor using a stable isotope-labeled compound.
    Kataoka M; Kojima C; Ueda K; Minami K; Higashino H; Sakuma S; Togashi K; Mutaguchi K; Yamashita S
    Drug Metab Pharmacokinet; 2016 Dec; 31(6):405-410. PubMed ID: 27876352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro and In Vivo Mechanistic Studies toward Understanding the Role of 1-Aminobenzotriazole in Rat Drug-Drug Interactions.
    Boily MO; Chauret N; Laterreur J; Leblond FA; Boudreau C; Duquet MC; Lévesque JF; Ste-Marie L; Pichette V
    Drug Metab Dispos; 2015 Dec; 43(12):1960-5. PubMed ID: 26438628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Aminobenzotriazole modulates oral drug pharmacokinetics through cytochrome P450 inhibition and delay of gastric emptying in rats.
    Stringer RA; Weber E; Tigani B; Lavan P; Medhurst S; Sohal B
    Drug Metab Dispos; 2014 Jul; 42(7):1117-24. PubMed ID: 24727486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1-aminobenzotriazole on the in vitro metabolism and single-dose pharmacokinetics of chlorzoxazone, a selective CYP2E1 substrate in Wistar rats.
    Muzeeb S; Pasha MK; Basha SJ; Mullangi R; Srinivas NR
    Xenobiotica; 2005 Aug; 35(8):825-38. PubMed ID: 16278194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
    Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
    Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pretreatment regimens of 1-aminobenzotriazole on metabolism and gastric emptying of probe compounds in rat.
    Padmanabhan S; Kaur H; Rao A; Saxena A; Gupta YK; Mariappan TT; Holenarsipur VK
    Xenobiotica; 2019 Jun; 49(6):646-654. PubMed ID: 29898636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of food pellets containing 1-aminobenzotriazole for longer term in vivo inhibition of cytochrome P450 in mice.
    Stringer R; Cordier V; Afatsawo C; Arabin P; Desrayaud S; Hoffmann L; Lehmann D; Lowe PJ; Risser F; Thiel J; Widmer T; Wipfli P; Bigaud M
    Xenobiotica; 2019 Jan; 49(1):13-21. PubMed ID: 29299977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Osmotic Pumps for Sustained Release of 1-Aminobenzotriazole and Inhibition of Cytochrome P450 Enzymes in Mice: Model Comparison with the Hepatic P450 Reductase Null Mouse.
    Stringer RA; Ferreira S; Rose J; Ronseaux S
    Drug Metab Dispos; 2016 Aug; 44(8):1213-6. PubMed ID: 27271368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CYP inhibitors on precocene I metabolism and toxicity in rat liver slices.
    Ly VT; Brock B
    Chem Biol Interact; 2011 Sep; 193(2):109-18. PubMed ID: 21741958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Cytochrome P450 Activity by 18β-Glycyrrhetic Acid and its Consequence on Buspirone Pharmacokinetics in Rats.
    Kim SB; Cho HJ; Kim YS; Kim DD; Yoon IS
    Phytother Res; 2015 Aug; 29(8):1188-94. PubMed ID: 26010440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Activation of Cholestatic Drug-Induced Bile Acid-Dependent Toxicity in Human Sandwich-Cultured Hepatocytes.
    Ogimura E; Tokizono M; Sekine S; Nakagawa T; Bando K; Ito K
    J Pharm Sci; 2017 Sep; 106(9):2509-2514. PubMed ID: 28465153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.